Autoimmune Disorder Drug Delivery Devices Market

1
The shifting trend toward increased use and
adoption of biologics and biosimilar drugs,
especially monoclonal antibodies had led to the
demand for better injectable drug delivery
devices.
AutoimmuneDisorder Drug DeliveryDevices
2
Global Autoimmune Disorder Drug Delivery Devices
Market, Million, 2019 -2030 10,686.5
Owing to the growing geriatric population, the
rising prevalence of autoimmune disorders, and
the increasing shift toward home healthcare in
the Asia-Paci?c region, the demand forautoimmune
disorder drug delivery devices is expected to
witness a high CAGR of 17.32 in the forecast
period.
10,000
Million
CAGR 15.25
8,000
1,685.2
6,500
4,000
2,000
0
2019
2030
Source Expert Interviews and BIS Analysis.
To access the full research report, please
follow the link- https//bisresearch.com/industry-
report/autoimmune-disorder-drug-delivery-devices-m
arket.html
3
Market Growth Drivers and Opportunities
ShortTerm Impact (1-2 Years)
Long Term Impact (8-10 Years)
Increased Prevalence of Autoimmune Disorders
TechnologicalAdvancementin the Field of
Pre-Filled Syringes Rising Geriatric
Population Surge of Biosimilars and Biologics in
the Pharmaceutical Market
HIGH
Device Connectivity to Ease the Competitive
Pressure
MEDIUM